misonidazole has been researched along with Carcinoma 256, Walker in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barthel, H; Dannenberg, C; Kluge, R; Kumar, P; Patt, M; Sabri, O; Seese, A; Sorger, D; Tannapfel, A; Wiebe, LI | 1 |
| Franko, AJ; Fuciarelli, AF; Kelly, DA; Koch, CJ; Miller, GG; Raleigh, JA | 1 |
2 other study(ies) available for misonidazole and Carcinoma 256, Walker
| Article | Year |
|---|---|
[18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors.
Topics: Animals; Carcinoma 256, Walker; Female; Misonidazole; Radiation-Sensitizing Agents; Rats; Tomography, Emission-Computed; Tumor Cells, Cultured | 2003 |
Fluorescence immunohistochemical detection of hypoxic cells in spheroids and tumours.
Topics: Animals; Carcinoma 256, Walker; Female; Immunohistochemistry; Male; Microscopy, Fluorescence; Misonidazole; Nitroimidazoles; Oxygen; Rabbits; Tumor Cells, Cultured | 1987 |